Dr Linda Armstrong’s career in the biopharmaceutical industry has spanned more than 20 years.   She is currently the US Novartis Foundation President and leads US Corporate Responsibility team at Novartis Pharmaceutical Corporation. 

Previously, Linda held executive roles in several pharmaceutical research and development organizations including most recently Head of Global Development for Respiratory and Allergy at Novartis.  In this position, she supported the development and approval of innovative therapies to address unmet medical needs in disease areas such as asthma, COPD, and cystic fibrosis. 

Linda has broad industry experience leading medical affairs, patient safety and clinical development teams over therapeutic areas including cardiovascular, respiratory and oncology.  Prior to joining Novartis, Linda held management positions at Schering-Plough Corporation (now Merck) and Pfizer Inc.

Linda received an AB degree from Harvard University and an MD degree from Yale University.  She completed medical training at Columbia Presbyterian Hospital in New York and completed pulmonology training and served as a faculty member at New York University School of medicine prior to joining the pharmaceutical industry.